ICU MEDICAL INCICUIEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 14.90% | 3.6M | flat | 2024-11-08 |
| The Vanguard Group | 10.11% | 2.4M | — | 2024-01-10 |
| S.S. OR | 9.90% | 2.4M | ▼ -0.90pp | 2024-11-14 |
| Fuller & Thaler Asset Management, Inc. | 5.78% | 1.4M | ▼ -0.32pp | 2024-11-12 |
| T. Rowe Price Investment Management, Inc. | 4.90% | 1.2M | — | 2023-12-11 |
| Wellington Management Group LLP | 3.84% | 937.5K | ▼ -2.69pp | 2024-11-08 |
| Smiths Group plc | 1.90% | 470.0K | ▼ -5.00pp | 2024-07-18 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-25 | Donald Abbey | Director | Other | 704 | $0.00 | $0 |
| 2026-03-15 | Ben Sousa | Chief Information Officer | Option exercise | 1.3K | $0.00 | $0 |
| 2026-03-15 | Vivek Jain | Chairman and CEO | Option exercise | 17.1K | $0.00 | $0 |
| 2026-03-15 | Vivek Jain | Chairman and CEO | Option exercise | 4.9K | $0.00 | $0 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 11.4K | $0.00 | $0 |
| 2026-03-15 | Voigtlander Christian B. | Chief Operating Officer | Option exercise | 3.2K | $0.00 | $0 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 5.7K | $0.00 | $0 |
| 2026-03-15 | Sanzone Virginia Ruth | VP, General Counsel | Option exercise | 1.6K | $0.00 | $0 |
| 2026-03-15 | Daniel Woolson | VP, GM-Infusion Capital | Option exercise | 2.9K | $0.00 | $0 |
| 2026-03-15 | Bonnell Brian Michael | Chief Financial Officer | Option exercise | 11.4K | $0.00 | $0 |
1–10 of 26
Page 1 / 3